Back to User profile » Dr Yingtao Lin

Papers published by Dr Yingtao Lin:


Original Research

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China

Zhou C, Wei J, Xu K, Lin Y, Zhang L, Li X

Risk Management and Healthcare Policy 2023, 16:2447-2458

Published Date: 15 November 2023

Original Research

How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study

Shang L, Lin Y, Fang W, Liu Y, Bao Y, Li X, Zhang Y

Risk Management and Healthcare Policy 2023, 16:1739-1753

Published Date: 4 September 2023

Original Research

Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Lin YT, Chen Y, Liu TX, Kuang F, Huang P

Cancer Management and Research 2021, 13:8219-8230

Published Date: 2 November 2021